Viewing Study NCT02719132


Ignite Creation Date: 2025-12-24 @ 9:25 PM
Ignite Modification Date: 2026-01-02 @ 12:40 AM
Study NCT ID: NCT02719132
Status: WITHDRAWN
Last Update Posted: 2016-05-20
First Post: 2016-03-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Effect of DapagliFLOzin on Quality of Life in Patients With Type 2 Diabetes in a Real Clinical PrActice
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes Mellitus Type 2 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Diabetes Mellitus type 2, dapagliflozin, quality of life View